Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced that it received notice of allowance of a patent from the US office of patents and trademarks for its DME drug Optina™. Ampio also received a notice of allowance of a similar patent from the Canadian Intellectual Property Office. These initial patents cover the North American territories and multiple additional patents for using Optina™ for the treatment of macular edema and diabetic retinopathy are pending worldwide.

According to Michael Macaluso, Ampio's CEO, "Optina™ is an ultra-low oral (capsule), not commercially available, dose of danazol for the treatment of DME. To our knowledge, no other oral drug to treat this condition exists and there is currently no drug approved by the FDA for this condition. The allowance of these patents in North America is an important step in the development and commercialization of this novel drug as they include multiple claims for the beneficial effects of ultra-low dose Optina™ on vascular hyperpermeability encountered in DME and other vascular leakage syndromes. These patents have an unusually long patent life that expires in 2030. In contrast, most drugs at this stage of development (just before a pivotal trial) have exhausted a large portion of their patent life. These patent claims provide especially strong protection because of the unexpected finding of efficacy only at the very low doses. Ampio is currently in discussions with potential partners to co-develop Optina™ for DME."

Dr. David Bar-Or, Chief Scientific Officer for Ampio, explained, "The mode of action of Optin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BOSTON , January 23, 2015 ... development company, is delighted to announce that the Malcolm ... Miles Congreve (Vice President of Chemistry), Fiona ... Weir (Chief Executive Officer and co-founder) for the seminal ...
(Date:1/22/2015)... is pleased to announce the appointment of Dr. ... Biochemistry. Scott joins the company after previous scientific leadership positions ... course of his nearly 20 year career in therapeutics ... recognized thought leader in the biosensor field and particularly ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 9DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 10DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 11DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 12DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 13DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 14DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 15Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 2Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 3Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 4Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 5Carl Zeiss Chooses AT&T as Global Provider For Comprehensive Communications Services 6
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Wales health department in Australia chose to understand the relationship ... ,The study conducted over three years covered a gamut of ... that a greater proportion of people born in Italy and ... Zealanders were physically more active than other ethnic groups. People ...
... condition in children. Children suffering from insomnia //and hypersomnia ... normal sleep. ,Sleep-disturbed children, with both insomnia ... than those with either insomnia or hypersomnia. ... and colleagues of the University of Pittsburgh, 553 children ...
... lawsuits can significantly slow or halt science's ability ... //factors produced by industry, a team of scientists ... ,The authors caution that litigation's effects could seriously ... a wide variety of diseases, including Parkinson's disease, ...
... discovered that a tiny piece of genetic code apparently goes ... gets there under its own internal code. ,MicroRNAs, already ... gum up larger strands of RNA that carry instructions for ... are, says Joshua Mendell, M.D., Ph.D., an assistant professor in ...
... joining a sugar to a short-chain fatty acid compound, ... that kills cancer // cells in lab tests. The ... been tested on animals or humans. Nevertheless, they believe ... deadly disease. ,“For a long time, ...
... Preston Mason and colleagues at Elucida Research has ... in nature, shows significant promise as a viable ... disease based on its exceptional antioxidant properties in ... and anecdotal human data, the results of the ...
Cached Medicine News:Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 2Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 3Health News:Renegade RNA: Clues to Cancer and Normal Growth 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
Comprehensive and structured clinical resource with access to more than 1,000 medical and surgical conditions, fully indexed with more than 7,500 items and medications....
... with BD Xstar Blade includes a specially ... blade in prodedure and handling. The ... grind-less process for manufacturing surgical blades. ... consistency. The arch style, single-bevel geometry ...
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
Medicine Products: